Legacy Products

  • small-lp-EV-035

    EV-035

  • small-lp-EV-077

    EV-077

  • small-lp-Pomecins

    Pomecins

Until 2010, Evolva was focused on the discovery and development of novel pharmaceuticals. Since then, Evolva has refocused onto its current business model. As a result three legacy products (EV-077, EV-035 and Pomecins) have been out-licensed or sold. Evolva still has certain success positions on these products.

cancel
  • Topped our upper estimate! Evolva raises CHF 86M ($86M). Cash position now > CHF 100M ($100M). https://t.co/aiPI46jsTK

Sign up to receive our
Press Releases!

Sign up